ostrigen.com
About company
strich Pharma USA, under the trade name “OstriGen,” is exploiting the powerful immune system of the ostrich to develop a revolutionary class of treatments and prophylaxes that are highly effective and economical. The company is developing prophylaxes and treatments for gastrointestinal diseases such as Clostridium difficile, cholera, E. coli, Salmonella, Shigella, and norovirus. OstriGen has worked with partners on developing antibodies to Ebola, MERS, and Zika. The company is involved in the active development of antibodies to zonulin – first as a diagnostic, and eventually to prevent onset of serious autoimmune diseases. In the future, these antibodies could become a key to microbiome health. OstriGen is actively developing products that exploit ostrich antibodies to promote weight loss and to regrow hair lost due to male and female pattern baldness.
